82 related articles for article (PubMed ID: 23151521)
1. In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.
Conforti P; Mas Monteys A; Zuccato C; Buckley NJ; Davidson B; Cattaneo E
Gene Ther; 2013 Jun; 20(6):678-85. PubMed ID: 23151521
[TBL] [Abstract][Full Text] [Related]
2. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
[TBL] [Abstract][Full Text] [Related]
3. Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.
Soldati C; Bithell A; Conforti P; Cattaneo E; Buckley NJ
J Neurochem; 2011 Feb; 116(3):415-25. PubMed ID: 21105876
[TBL] [Abstract][Full Text] [Related]
4. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
Zuccato C; Belyaev N; Conforti P; Ooi L; Tartari M; Papadimou E; MacDonald M; Fossale E; Zeitlin S; Buckley N; Cattaneo E
J Neurosci; 2007 Jun; 27(26):6972-83. PubMed ID: 17596446
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
6. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.
Charbord J; Poydenot P; Bonnefond C; Feyeux M; Casagrande F; Brinon B; Francelle L; Aurégan G; Guillermier M; Cailleret M; Viegas P; Nicoleau C; Martinat C; Brouillet E; Cattaneo E; Peschanski M; Lechuga M; Perrier AL
Stem Cells; 2013 Sep; 31(9):1816-28. PubMed ID: 23712629
[TBL] [Abstract][Full Text] [Related]
7. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
[TBL] [Abstract][Full Text] [Related]
8. SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease.
Leone S; Mutti C; Kazantsev A; Sturlese M; Moro S; Cattaneo E; Rigamonti D; Contini A
Bioorg Med Chem; 2008 May; 16(10):5695-703. PubMed ID: 18406155
[TBL] [Abstract][Full Text] [Related]
9. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
Conforti P; Ramos C; Apostol BL; Simmons DA; Nguyen HP; Riess O; Thompson LM; Zuccato C; Cattaneo E
Mol Cell Neurosci; 2008 Sep; 39(1):1-7. PubMed ID: 18571429
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.
Ebert AD; Barber AE; Heins BM; Svendsen CN
Exp Neurol; 2010 Jul; 224(1):155-62. PubMed ID: 20227407
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific regulation of RE-1 silencing transcription factor (REST) target genes.
Hohl M; Thiel G
Eur J Neurosci; 2005 Nov; 22(9):2216-30. PubMed ID: 16262660
[TBL] [Abstract][Full Text] [Related]
13. REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activation.
Tabuchi A; Yamada T; Sasagawa S; Naruse Y; Mori N; Tsuda M
Biochem Biophys Res Commun; 2002 Jan; 290(1):415-20. PubMed ID: 11779185
[TBL] [Abstract][Full Text] [Related]
14. AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease.
Alto LT; Chen X; Ruhn KA; Treviño I; Tansey MG
PLoS One; 2014; 9(5):e96544. PubMed ID: 24824433
[TBL] [Abstract][Full Text] [Related]
15. Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease.
Johnson R; Richter N; Jauch R; Gaughwin PM; Zuccato C; Cattaneo E; Stanton LW
Physiol Genomics; 2010 May; 41(3):269-74. PubMed ID: 20179156
[TBL] [Abstract][Full Text] [Related]
16. The retrograde delivery of adenovirus vector carrying the gene for brain-derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy mice.
Uchida K; Nakajima H; Hirai T; Yayama T; Chen K; Guerrero AR; Johnson WE; Baba H
Spine (Phila Pa 1976); 2012 Dec; 37(26):2125-35. PubMed ID: 22648027
[TBL] [Abstract][Full Text] [Related]
17. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.
Johnson R; Buckley NJ
Neuromolecular Med; 2009; 11(3):183-99. PubMed ID: 19458943
[TBL] [Abstract][Full Text] [Related]
18. Identification of REST-regulated genes and pathways using a REST-targeted antisense approach.
Sedaghat Y; Bui HH; Mazur C; Monia BP
Nucleic Acid Ther; 2013 Dec; 23(6):389-400. PubMed ID: 24329414
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs in Huntington's disease neurodegeneration.
Johnson R
Neurobiol Dis; 2012 May; 46(2):245-54. PubMed ID: 22202438
[TBL] [Abstract][Full Text] [Related]
20. Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.
Chen GL; Ma Q; Goswami D; Shang J; Miller GM
J Cell Mol Med; 2017 Nov; 21(11):2974-2984. PubMed ID: 28524599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
